- Home
- TRML vs YSG Comparison
TRML vs YSG Comparison
Compare TRML & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- YSG
- Stock Information
- Founded
- TRML 2021
- YSG 2016
- Country
- TRML United States
- YSG China
- Employees
- TRML N/A
- YSG 1505
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- YSG Package Goods/Cosmetics
- Sector
- TRML Health Care
- YSG Consumer Discretionary
- Exchange
- TRML Nasdaq
- YSG Nasdaq
- Market Cap
- TRML 419.1M
- YSG 444.5M
- IPO Year
- TRML N/A
- YSG 2020
- Fundamental
- Price
- TRML $23.01
- YSG $4.51
- Analyst Decision
- TRML Strong Buy
- YSG
- Analyst Count
- TRML 3
- YSG 0
- Target Price
- TRML $65.00
- YSG N/A
- AVG Volume (30 Days)
- TRML 187.7K
- YSG 308.8K
- Earning Date
- TRML 11-07-2024
- YSG 11-20-2024
- Dividend Yield
- TRML N/A
- YSG N/A
- EPS Growth
- TRML N/A
- YSG N/A
- EPS
- TRML N/A
- YSG N/A
- Revenue
- TRML N/A
- YSG $472,960,724.00
- Revenue This Year
- TRML N/A
- YSG $2.29
- Revenue Next Year
- TRML N/A
- YSG $5.70
- P/E Ratio
- TRML N/A
- YSG N/A
- Revenue Growth
- TRML N/A
- YSG N/A
- 52 Week Low
- TRML $12.12
- YSG $1.99
- 52 Week High
- TRML $48.31
- YSG $4.89
- Technical
- Relative Strength Index (RSI)
- TRML 37.25
- YSG 74.02
- Support Level
- TRML $25.58
- YSG $3.68
- Resistance Level
- TRML $27.51
- YSG $4.13
- Average True Range (ATR)
- TRML 1.81
- YSG 0.23
- MACD
- TRML -0.61
- YSG 0.05
- Stochastic Oscillator
- TRML 10.76
- YSG 82.50
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The Group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.